Differential long-term efficacy of biologic and small-molecule therapies by disease location in moderate-to-severe luminal Crohn's disease: a systematic review and network meta-analysis.
Аннотация
BACKGROUND AND AIMS: Treatment efficacy in Crohn's disease (CD) may vary according to disease location. We aimed to evaluate the long-term efficacy of biological and small molecule therapies in moderate-to-severe luminal CD stratified by CD location.
DESIGN
We conducted a systematic review and Bayesian network meta-analysis (NMA) of randomized controlled trials (RCTs) in adults (aged ≥18 years) with moderate-to-severe CD (Crohn's Disease Activity Index [CDAI] 220-450), identified through PubMed, Embase, and CENTRAL to August 12, 2025. Predefined outcomes included clinical remission (CDAI < 150) and endoscopic response (≥50% reduction in Simple Endoscopic Score-CD (SES-CD) at week 52 (range, 44-56 weeks), stratified by Montreal disease location and trial design.
RESULTS
Eighteen RCTs (including 4697 patients) evaluating adalimumab, infliximab, vedolizumab, ustekinumab, mirikizumab, risankizumab, guselkumab, and upadacitinib were included. Clinical remission rates were lowest in isolated ileal disease, and only guselkumab regimens (200 mg/100 mg: relative risk, 3.4 [95% CI, 1.3-8.9]) were statistically superior to placebo for maintenance of clinical remission at week 52. In isolated colonic disease, upadacitinib 30 mg ranked highest in re-randomized trials and with significant location-dependent differences (efficacy ratio [EF] for colonic vs ileal is 4.6 [95% CI, 1.7-12.6], EF for ileocolonic vs ileal is 3.45 [95% CI, 1.2-9.6]), consistent with endoscopic response rates. No location-dependent differences were observed for other agents.
CONCLUSION
Relative efficacy of advanced therapies in luminal CD varied by disease location. These findings support consideration of disease location in personalized treatment decision-making to improve clinical outcomes.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.